vs
ON24 INC.（ONTF）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是ON24 INC.的1.0倍（$35.5M vs $34.6M），ON24 INC.净利率更高（-18.8% vs -304.2%，领先285.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -5.6%），ON24 INC.自由现金流更多（$-2.2M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -4.2%）
ON24 INC.是一家总部位于美国旧金山的企业，为B2B企业的营销与销售团队提供基于云的SaaS服务，开发并提供网络研讨会、虚拟会议、内容中心与着陆页应用，2023年其服务范围已扩展至生成式AI领域。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
ONTF vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.0倍
$34.6M
营收增速更快
RXRX
高出687.3%
-5.6%
净利率更高
ONTF
高出285.5%
-304.2%
自由现金流更多
ONTF
多$45.1M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-4.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $34.6M | $35.5M |
| 净利润 | $-6.5M | $-108.1M |
| 毛利率 | 74.9% | 59.8% |
| 营业利润率 | -23.5% | -304.8% |
| 净利率 | -18.8% | -304.2% |
| 营收同比 | -5.6% | 681.7% |
| 净利润同比 | 26.8% | 39.6% |
| 每股收益（稀释后） | $-0.15 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ONTFRXRX
| Q4 25 | $34.6M | $35.5M | ||
| Q3 25 | $34.6M | $5.2M | ||
| Q2 25 | $35.3M | $19.2M | ||
| Q1 25 | $34.7M | $14.7M | ||
| Q4 24 | $36.7M | $4.5M | ||
| Q3 24 | $36.3M | $26.1M | ||
| Q2 24 | $37.3M | $14.4M | ||
| Q1 24 | $37.7M | $13.8M |
净利润ONTFRXRX
| Q4 25 | $-6.5M | $-108.1M | ||
| Q3 25 | $-6.4M | $-162.3M | ||
| Q2 25 | $-7.3M | $-171.9M | ||
| Q1 25 | $-8.7M | $-202.5M | ||
| Q4 24 | $-8.9M | $-178.9M | ||
| Q3 24 | $-11.4M | $-95.8M | ||
| Q2 24 | $-11.2M | $-97.5M | ||
| Q1 24 | $-10.7M | $-91.4M |
毛利率ONTFRXRX
| Q4 25 | 74.9% | 59.8% | ||
| Q3 25 | 74.7% | -183.8% | ||
| Q2 25 | 75.1% | -4.9% | ||
| Q1 25 | 73.8% | -48.0% | ||
| Q4 24 | 74.5% | -181.4% | ||
| Q3 24 | 74.3% | 53.7% | ||
| Q2 24 | 74.5% | 36.2% | ||
| Q1 24 | 74.1% | 19.1% |
营业利润率ONTFRXRX
| Q4 25 | -23.5% | -304.8% | ||
| Q3 25 | -23.1% | -3327.6% | ||
| Q2 25 | -26.0% | -916.8% | ||
| Q1 25 | -30.1% | -1297.9% | ||
| Q4 24 | -32.1% | -4042.4% | ||
| Q3 24 | -36.7% | -377.1% | ||
| Q2 24 | -35.0% | -697.4% | ||
| Q1 24 | -33.1% | -698.4% |
净利率ONTFRXRX
| Q4 25 | -18.8% | -304.2% | ||
| Q3 25 | -18.4% | -3135.3% | ||
| Q2 25 | -20.6% | -894.2% | ||
| Q1 25 | -25.1% | -1373.3% | ||
| Q4 24 | -24.2% | -3935.5% | ||
| Q3 24 | -31.4% | -367.5% | ||
| Q2 24 | -29.9% | -676.6% | ||
| Q1 24 | -28.4% | -662.4% |
每股收益（稀释后）ONTFRXRX
| Q4 25 | $-0.15 | $-0.17 | ||
| Q3 25 | $-0.15 | $-0.36 | ||
| Q2 25 | $-0.17 | $-0.41 | ||
| Q1 25 | $-0.21 | $-0.50 | ||
| Q4 24 | $-0.21 | $-0.56 | ||
| Q3 24 | $-0.27 | $-0.34 | ||
| Q2 24 | $-0.27 | $-0.40 | ||
| Q1 24 | $-0.26 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.0M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $139.4M | $1.1B |
| 总资产 | $228.4M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资ONTFRXRX
| Q4 25 | $37.0M | $743.3M | ||
| Q3 25 | $47.2M | $659.8M | ||
| Q2 25 | $37.7M | $525.1M | ||
| Q1 25 | $26.8M | $500.5M | ||
| Q4 24 | $14.9M | $594.4M | ||
| Q3 24 | $11.0M | $427.6M | ||
| Q2 24 | $15.5M | $474.3M | ||
| Q1 24 | $18.3M | $296.3M |
总债务ONTFRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益ONTFRXRX
| Q4 25 | $139.4M | $1.1B | ||
| Q3 25 | $144.3M | $1.0B | ||
| Q2 25 | $150.0M | $919.1M | ||
| Q1 25 | $153.7M | $933.9M | ||
| Q4 24 | $159.4M | $1.0B | ||
| Q3 24 | $164.9M | $524.6M | ||
| Q2 24 | $170.8M | $584.4M | ||
| Q1 24 | $174.4M | $401.2M |
总资产ONTFRXRX
| Q4 25 | $228.4M | $1.5B | ||
| Q3 25 | $224.8M | $1.4B | ||
| Q2 25 | $235.1M | $1.3B | ||
| Q1 25 | $245.8M | $1.3B | ||
| Q4 24 | $251.0M | $1.4B | ||
| Q3 24 | $250.9M | $726.5M | ||
| Q2 24 | $259.0M | $775.9M | ||
| Q1 24 | $269.2M | $557.8M |
负债/权益比ONTFRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.1M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-2.2M | $-47.3M |
| 自由现金流率自由现金流/营收 | -6.4% | -133.1% |
| 资本支出强度资本支出/营收 | 3.3% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.0M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流ONTFRXRX
| Q4 25 | $-1.1M | $-46.1M | ||
| Q3 25 | $2.5M | $-117.4M | ||
| Q2 25 | $2.6M | $-76.4M | ||
| Q1 25 | $3.4M | $-132.0M | ||
| Q4 24 | $985.0K | $-115.4M | ||
| Q3 24 | $295.0K | $-59.2M | ||
| Q2 24 | $1.4M | $-82.2M | ||
| Q1 24 | $2.1M | $-102.3M |
自由现金流ONTFRXRX
| Q4 25 | $-2.2M | $-47.3M | ||
| Q3 25 | $2.2M | $-117.6M | ||
| Q2 25 | $2.1M | $-79.6M | ||
| Q1 25 | $1.9M | $-133.8M | ||
| Q4 24 | $424.0K | $-116.7M | ||
| Q3 24 | $143.0K | $-63.8M | ||
| Q2 24 | $898.0K | $-83.4M | ||
| Q1 24 | $1.1M | $-109.0M |
自由现金流率ONTFRXRX
| Q4 25 | -6.4% | -133.1% | ||
| Q3 25 | 6.2% | -2272.5% | ||
| Q2 25 | 5.9% | -413.9% | ||
| Q1 25 | 5.6% | -907.4% | ||
| Q4 24 | 1.2% | -2567.7% | ||
| Q3 24 | 0.4% | -244.6% | ||
| Q2 24 | 2.4% | -578.5% | ||
| Q1 24 | 2.9% | -789.9% |
资本支出强度ONTFRXRX
| Q4 25 | 3.3% | 3.5% | ||
| Q3 25 | 1.1% | 4.7% | ||
| Q2 25 | 1.4% | 16.4% | ||
| Q1 25 | 4.2% | 12.4% | ||
| Q4 24 | 1.5% | 28.6% | ||
| Q3 24 | 0.4% | 17.5% | ||
| Q2 24 | 1.3% | 8.2% | ||
| Q1 24 | 2.8% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
